MyAverix Finance
KQ · Healthcare
U2Bio Co., Ltd. (221800)
Diagnostics & Research
U2Bio Co., Ltd. (221800) is listed on KQ in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 221800
U2Bio Co., Ltd. (221800) — FAQ
What is 221800's P/E ratio?
The price-to-earnings (P/E) ratio for U2Bio Co., Ltd. (221800) is 18.00 (data as of 2026-05-23).
Does U2Bio Co., Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for U2Bio Co., Ltd. (221800). Check the MyAverix Finance app for the latest dividend data.
What sector is U2Bio Co., Ltd. in?
U2Bio Co., Ltd. (221800) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 221800 listed on?
221800 is listed on KQ.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.